Research Project
Grant-in-Aid for Scientific Research (C)
Nonalcoholic steatohepatitis (NASH) is a growing medical problem, and can progress to liver cirrhosis and hepatocellular carcinoma. Now, liver biopsy remains the gold standard for the diagnosis and the grading liver disease severity in NASH patients. However, liver biopsy is an invasive test, and repeated liver biopsy for the estimation of NASH progression is hard to perform. Therefore, noninvasive NASH biomarkers are needed. We investigated pathophysiology of NASH focusing on adipocytokine and oligosaccharide. We found that lack of secreted frizzled related protein 5 accelerated the liver fibrosis progression. In addition, we established three glyco-biomarkers for NASH. Serum fucosylated haptoglobin and Mac-2 binding protein levels are useful for the NASH diagnosis, and suitable for the prediction of ballooning hepatocyte presence and liver fibrosis severity, respectively. We also found serum fetuin-A levels were decreased with the liver fibrosis progression of NASH patients.
All 2015 2014 2013 2012 Other
All Journal Article (29 results) (of which Peer Reviewed: 29 results, Open Access: 7 results, Acknowledgement Compliant: 9 results) Presentation (14 results) Book (7 results) Remarks (1 results)
Liver Int
Volume: 35 Issue: 3 Pages: 925-35
10.1111/liv.12478
Clin Chem Lab Med
Volume: 53 Issue: 1 Pages: 95-102
10.1515/cclm-2014-0427
Mol Med Rep.
Volume: 5 Issue: 5 Pages: 3573-84
10.3892/mmr.2015.3168
Volume: in press Issue: 8 Pages: 2017-26
10.1111/liv.12757
World J Gastroenterol
Volume: 21 Issue: 13 Pages: 3876-87
10.3748/wjg.v21.i13.3876
Am J Physiol Gastrointest Liver Physiol
Volume: 308 Issue: 7 Pages: 613-624
10.1152/ajpgi.00289.2014
Sci Rep
Volume: in press Issue: 1 Pages: 925-35
10.1038/srep08264
Volume: in press Issue: 8 Pages: 2062-2062
10.1111/liv.12833
Clin Chim Acta
Volume: in press Pages: 30-6
10.1016/j.cca.2015.03.037
J Gastroenterol.
Volume: 49 Issue: 2 Pages: 305-316
10.1007/s00535-013-0780-7
Biomed Rep
Volume: 2 Pages: 213-16
Pancreas
Volume: 43 Issue: 7 Pages: 1032-1041
10.1097/mpa.0000000000000159
J Proteome Res
Volume: 13 Issue: 11 Pages: 4869-77
10.1021/pr5004399
130007499829
日本消化器病学会雑誌
Volume: 111 Pages: 25-34
130003383340
Hepatol Res
Volume: 印刷中 Issue: 1 Pages: 102-13
10.1111/hepr.12092
Biochem Biophys Res Commun.
Volume: 437 Issue: 2 Pages: 185-191
10.1016/j.bbrc.2013.05.097
Proteomics Clin Appl.
Volume: 6 Issue: 9-10 Pages: 648-656
10.1002/prca.201200137
Volume: 43(3) Issue: 3 Pages: 238-48
10.1111/j.1872-034x.2012.01066.x
10031183465
Hepatol Res.
Volume: 43 Issue: 4 Pages: 401-412
10.1111/j.1872-034x.2012.01082.x
10031194552
Inflamm Bowel Dis.
Volume: 19(2) Issue: 2 Pages: 321-31
10.1097/mib.0b013e318280eade
Volume: 417 Pages: 48-53
10.1016/j.cca.2012.12.014
PLoS One
Volume: 8
Volume: 43 Issue: 4 Pages: 384-393
10.1111/j.1872-034x.2012.01074.x
10031194550
Glycobiology
Volume: 22(6) Issue: 6 Pages: 778-87
10.1093/glycob/cws012
Am J Physiol Gastrointest Liver Physiol.
Volume: 302(Epub 2012 Feb 9) Issue: 8 Pages: G773-G780
10.1152/ajpgi.00324.2011
J. Proteome Res
Volume: 11(5) Issue: 5 Pages: 2798-806
10.1021/pr201154k
BMB Rep
Volume: 45 Pages: 554-9
医学と薬学
Volume: 68 Pages: 435-435
http://www.dma.jim.osaka-u.ac.jp/view?l=ja&u=1660